STAT+: Apollo acquires minority stake in Sofinnova, extending private equity dealmaking in life sciences
Private equity giant Apollo Global Management is spending $1 billion for a piece of one of the biotech industry’s oldest venture capital firms.
Apollo is acquiring a minority stake in the Paris-based VC Sofinnova Partners and will invest up to $1 billion in Sofinnova’s investment funds, the firms announced Monday.
